SEC Tracker
Get the app

Windward Bio Group

In registration · F-1/A filed Oct 30, 2026

Windward Bio Group AG is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for respiratory and dermatologic diseases.

Legal name
WINDWARD BIO GROUP AG
CIK
2145089
Industry
Biological products (no diagnostic substances)
Incorporated in
Switzerland

IPO registration

Public filing · F-1/A filed Oct 30, 2026

  1. Amended registration (foreign issuer) F-1/AWhat changed
  2. Registration filed (foreign issuer) F-1What changed
  3. Amended draft registration DRS/AWhat changed
  4. Amended draft registration DRS/AWhat changed
  5. Amended draft registration DRS/AWhat changed
  6. Draft registration, filed confidentially DRSFirst filing

The F-1/A, section by section

  1. Prospectus summary 6 points
  2. Risk factors 6 points
  3. Use of proceeds 3 points
  4. Dilution 6 points
  5. Management’s discussion and analysis of financial condition and results of operations 6 points
  6. Business 6 points
  7. Management 6 points
  8. Principal shareholders 6 points

Every filing comes from WINDWARD BIO GROUP AG on EDGAR. Check the filing before you rely on it.